Patents
US 9845285 B2: Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
- Granted
- 2017-12-19
- Filed
- 2015-12-03 application 14957962
- Type
- Utility · 20 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present invention provides crystalline solid and amorphous forms of (−)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (−)-halofenate.
Source: PVGPATDIS, file of 2026-04-10 (ipg171219.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| CymaBay Therapeutics, Inc. 43 patents | US company or organization | Newark, CA | CymaBay Therapeutics, Inc. Form D issuer EXACT high confidence: identical full name and state CYMABAY THERAPEUTICS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
| Diatex Co., Ltd. 11 patents | Foreign company or organization | San Antonio, TX | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Edward D. Daugs | Midland, MI | 25 | PVGPATDIS, file of 2026-04-10 | |
| Eric J. Hagen | Lafayette, IN | 11 | PVGPATDIS, file of 2026-04-10 | |
| Jason A. Hanko | West Lafayette, IN | 14 | PVGPATDIS, file of 2026-04-10 | |
| David H. Louks | Saginaw, MI | 4 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07C | Acyclic or carbocyclic compounds | C07C233/18 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/0053 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P3/06 | PVGPATDIS, file of 2026-04-10 |
| C07B | General methods of organic chemistry; apparatus therefor | C07B2200/07 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2016-06-29 | Assignment Assignment of assignor's interest | CYMABAY THERAPEUTICS, INC. signed 2016-06-29 | DIATEX, INC. SAN ANTONIO, TX | 39045/152 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.